75 related articles for article (PubMed ID: 2784601)
1. [Do HLA-B37 and HLA-B27 antigens cross react?].
Májský A
Vnitr Lek; 1989 Jan; 35(1):50-1. PubMed ID: 2784601
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric HLA-B27 screening: cross-reactivity patterns of commercially available anti-HLA-B27 monoclonal antibodies with other HLA-B antigens.
Levering WH; Wind H; Sintnicolaas K; Hooijkaas H; Gratama JW
Cytometry B Clin Cytom; 2003 Jul; 54(1):28-38. PubMed ID: 12827665
[TBL] [Abstract][Full Text] [Related]
3. HLA-B27 screening by flow cytometry.
Lingenfelter B; Fuller TC; Hartung L; Hunter J; Wittwer C
Cytometry; 1995 Jun; 22(2):146-9. PubMed ID: 7587746
[TBL] [Abstract][Full Text] [Related]
4. A common epitope between HLA-B27, -B13 and -B37 alloantigens defined by a monoclonal antibody.
Bourel D; Fauchet R; Dejour G; Bouhallier O; Merdrignac G; Chales G; Genetet B
Tissue Antigens; 1987 Sep; 30(3):97-103. PubMed ID: 2447679
[TBL] [Abstract][Full Text] [Related]
5. Cross-reactive T cell clones from unrelated individuals reveal similarities in peptide presentation between HLA-B27 and HLA-DR2.
López D; Barber DF; Villadangos JA; López de Castro JA
J Immunol; 1993 Apr; 150(7):2675-86. PubMed ID: 7681078
[TBL] [Abstract][Full Text] [Related]
6. [Study of HLA antigens A and B and their cross reactions in B27-negative ankylosing spondylarthritis].
Dreyfus P; Geay D; Cambon H; Daupleix D
Rev Rhum Mal Osteoartic; 1984 May; 51(5):269-72. PubMed ID: 6610919
[TBL] [Abstract][Full Text] [Related]
7. Overlapping peptide-binding specificities of HLA-B27 and B39: evidence for a role of peptide supermotif in the pathogenesis of spondylarthropathies.
Sobao Y; Tsuchiya N; Takiguchi M; Tokunaga K
Arthritis Rheum; 1999 Jan; 42(1):175-81. PubMed ID: 9920028
[TBL] [Abstract][Full Text] [Related]
8. External quality assessment of flow cytometric HLA-B27 typing.
Levering WH; van den Beemd R; te Marvelde JG; van Beers WA; Hooijkaas H; Sintnicolaas K; Gratama JW
Cytometry; 2000 Apr; 42(2):95-105. PubMed ID: 10797446
[TBL] [Abstract][Full Text] [Related]
9. Long-term stabilized blood samples as controls for flow cytometric HLA-B27 screening: a feasibility study.
Levering WH; Wind H; Granger V; Sintnicolaas K; Hooijkaas H; Reilly JT; Gratama JW; Barnett D
Cytometry B Clin Cytom; 2008 May; 74(3):169-81. PubMed ID: 18200592
[TBL] [Abstract][Full Text] [Related]
10. Four cytotoxic human-human hybridoma antibodies that react with HLA-B27.
Hansen T; Bratlie A; Hannestad K
Tissue Antigens; 1988 Nov; 32(5):267-77. PubMed ID: 2464858
[TBL] [Abstract][Full Text] [Related]
11. The role of Klebsiella in the pathogenesis of ankylosing spondylitis. II Evidence for a specific B27-associated marker on the lymphocytes of patients with ankylosing spondylitis.
Geczy AF; Seager K; Bashir HV; de Vere-Tyndall A; Edmonds J
J Clin Lab Immunol; 1980 Jan; 3(1):23-8. PubMed ID: 7381924
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of four monoclonal antibodies against HLA-B27 for their reliability in HLA-B27 typing with flow cytometry (FC): comparison with the classic microlymphocytotoxic test (MLCT).
Neumüller J; Schwartz DW; Dauber E; Mayr WR
Cytometry; 1996 Sep; 26(3):209-15. PubMed ID: 8889393
[TBL] [Abstract][Full Text] [Related]
13. [Determination of HLA-B27 antigen subtypes from the results of lymphocyte reactions to anti-HLA-B27 sera].
Májský A
Vnitr Lek; 1993 Jan; 39(1):49-53. PubMed ID: 8517042
[TBL] [Abstract][Full Text] [Related]
14. A reinvestigation of the cross-reactivity between Klebsiella and HLA-B27 in the aetiology of ankylosing spondylitis.
Georgopoulos K; Dick WC; Goodacre JA; Pain RH
Clin Exp Immunol; 1985 Dec; 62(3):662-71. PubMed ID: 3878755
[TBL] [Abstract][Full Text] [Related]
15. Recognition of B cells epitopes of the Klebsiella pneumoniae GroEL-like protein by HLA-B27 positive subjects.
Cancino-Díaz M; Ayala-Narváez H; Burgos-Vargas R; Selene Reyes-López A; Tovar-Castillo L; Domínguez-López L; Granados Arreola J; Jiménez-Zamudio L; García-Latorre E
Microb Pathog; 2000 Apr; 28(4):211-20. PubMed ID: 10764612
[TBL] [Abstract][Full Text] [Related]
16. Determination of HLA-B27 subtypes in Iranian patients with ankylosing spondylitis.
Nicknam MH; Mahmoudi M; Amirzargar AA; Ganjalikhani Hakemi M; Khosravi F; Jamshidi AR; Amirkhani A; Ansaripour B; Pourpak Z; Moin M; Nikbin B
Iran J Allergy Asthma Immunol; 2008 Mar; 7(1):19-24. PubMed ID: 18322308
[TBL] [Abstract][Full Text] [Related]
17. Routine molecular genotyping of HLA-B27 in spondyloarthropathies overcomes the obstacles of serological typing and reveals an increased B *2702 frequency in ankylosing spondylitis.
Frankenberger B; Breitkopf S; Albert E; Scholz S; Keller E; Schattenkirchner M; Weiss EH; Kellner H
J Rheumatol; 1997 May; 24(5):899-903. PubMed ID: 9150078
[TBL] [Abstract][Full Text] [Related]
18. HLA-B40, B18, B27, and B37 allele discrimination using group-specific amplification and SSCP method.
Bannai M; Tokunaga K; Lin L; Ogawa A; Fujisawa K; Juji T
Hum Immunol; 1996 Apr; 46(2):107-13. PubMed ID: 8727209
[TBL] [Abstract][Full Text] [Related]
19. Reaction of anti-HLA-B monoclonal antibodies with envelope proteins of Shigella species. Evidence for molecular mimicry in the spondyloarthropathies.
Raybourne RB; Bunning VK; Williams KM
J Immunol; 1988 May; 140(10):3489-95. PubMed ID: 3283236
[TBL] [Abstract][Full Text] [Related]
20. Automated HLA-B27 testing using the FACSPrep/FACScan system.
Reynolds WM; Evans PR; Lane AC; Howell WM; Wilson PJ; Wong R; Smith JL
Cytometry; 1994 Jun; 18(2):109-15. PubMed ID: 7924699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
